person · Reporting owner
Favit-Van Pelt Antonella R.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Solana CoHSDT · Entity 6630 | Chief Medical Officer | July 02, 2025 | July 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Solana Co
Report date July 02, 2025 · Filed July 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.76 · Expires 2035-07-01 | Direct | 17,500 |
Reported balance
After 2025-07-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-07-02 · Grant · Acquired 17,500 · Balance 17,500 F1: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2025 Filed Jul 4, 2025 00:00 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.76 | $0.00 |
DisclosureSEC source: 0001140361-25-024938 · form4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Class A Common Stock · 17,500 shares Expires 2035-07-01 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:10 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 95,892 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001140361-25-000616 · form4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,892 Underlying: Class A Common Stock · 95,892 shares Expires 2035-01-05 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on March 31, 2025, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 21:00 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 277,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001140361-24-032528 · form4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,000 Underlying: Class A Common Stock · 277,000 shares Expires 2034-07-01 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 62.5% of the options vested immediately upon grant, and the remaining options vest in a series of ten (10) successive equal quarterly installments on the last day of each quarter starting on September 30, 2024, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| February 14, 2023 Filed Feb 17, 2023 00:12 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 1,463,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001140361-23-007528 · form4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,000 Underlying: Common Stock · 1,463,000 shares Expires 2033-02-13 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 20:45 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001104659-22-100061 · tm2225892-2_4seq1.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-09-12 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:10 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001209191-22-011219 · doc4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 20:10 UTC | Solana Co HSDT · Entity 6630 | GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001209191-21-045988 · doc4.xml · derivative · entry 1 Favit-Van Pelt Antonella R. · CIK 0001871533 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-07-06 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2021 Inducement Plan. The options vest in four equal installments on each of the first, second, third and fourth anniversaries of the date of grant, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.